张璞,李容瑢,李一欣,李占淳,梁文妹
ZHANG Pu,LI Rongrong,LI Yixin,LI Zhanchun,LIANG Wenmei

• 1:贵阳医学院组织学与胚胎学教研室
• 2:贵阳医学院
• 3:遵义医专

摘要(Abstract)：

目的:构建1型糖尿病(T1DM)小鼠模型,研究T1DM小鼠胰岛B细胞表达胰岛素(Ins)及血清Ins水平的变化。方法:正常雄性C57BL/6J小鼠104只,随机分为实验组、盐水对照组和正常对照组;模型的诱导采用连续多次小剂量链脲佐菌素给药法(MLDSTZ)制作T1DM小鼠模型;分别于注射后第3、7、10、14、21及28天检测小鼠的空腹血糖、体重,取血清及胰腺组织,应用免疫组织化学SABC单染法观察胰岛B细胞Ins表达,图像分析、形态计量法检测Ins阳性细胞平均灰度值、计算面数密度(NA),酶联免疫吸附法(ELISA)检测血清Ins水平。结果:与正常及盐水对照组比较,实验组小鼠第10天以后出现明显的多饮、多尿、活动减少等典型糖尿病(DM)表现,空腹血糖水平从实验第14天开始明显升高,以第28天组最高,差异有统计学意义(P<0.01);实验组小鼠胰岛面积有所减小。胰岛Ins阳性细胞在实验第10、14及21天组染色加深,免疫反应强度增强,平均灰度值降低,差异有统计学意义(P<0.01);NA从第7天开始减小,呈逐渐下降趋势,与正常及盐水对照组比较,差异有统计学意义(P<0.01);实验组小鼠与对照组相比,血清Ins浓度从实验第7天后均处于较低水平。结论:T1DM模型小鼠胰岛面积减小,胰岛B细胞数量减少,合成和分泌Ins总量减少且表达下调,血清Ins水平下降。
Objective: To establish mouse models of type 1 diabetes mellitus( T1DM),and to investigate the expression changes of insulin in islet B cells and serum insulin levels of mice with T1DM. Methods: A total of 104 normal male C57BL /6J mice were randomly divided into three groups: experiment group( EG),saline control group( SCG) and normal control group( NCG). Mouse models of T1DM were induced through injecting low dose of streptozotocin( MLDSTZ) continuously and repeatedly. Fasting blood-glucose and weights of the mice were measured subsequently on the 3rd,7th,10th, 14th,21stand 28thdays after the first injection,and the serum and pancreatic tissues of the mice were taken at the same time. The expressions of Ins in islets were detected by immunohistochemical SABC staining method. Islet area,numerical density on area( NA),and Ins positive cell number in islet were detected with image analysis method. Serum Ins levels were determined with enzyme linked immunosorbent assay( ELISA) method. Results: Compared with NCG and SCG,mice in EG appeared typical diabetes mellitus manifestations such as polydipsia,polyuria and less activity on the 10thday. Fasting blood-glucose level was increased from the 14thday onwards,and with the highest value on the 28th day( P ﹤ 0. 01); The area of islets in EG was reduced. Compared with NCG and SCG,the immune staining intensity of islet Ins immunoreaction( Ins-IR) cells was enhanced on the 10th,14th,21stdays in EG,and the mean gray value was decreased at the same time( P ﹤ 0. 01); NAof Ins-IR cells was apparently decreased in EG from the 7thday onwards( P ﹤ 0. 01); The ELISA results showed that the concentration of serum insulin in EG was at a low level from the 7thday onwards. Conclusions: The area of pancreatic islet of T1DM mice is reduced,the number of B cells in islet is decreased,the synthesis and secretion of insulin is down-regulated,the serum insulin level is low.

关键词(KeyWords)： 链脲佐菌素;糖尿病,胰岛素依赖型;模型,动物;胰岛素
streptozotocin;diabetes mellitus,insulin-dependent;model,animal;insulin

Abstract:

Keywords:

基金项目(Foundation): 贵州省国际合作计划项目[黔科合外G字(2010)7017号];; 贵州省教育厅“125”重大科技专项[黔教合重大专项字(2012)007号]

作者(Author): 张璞,李容瑢,李一欣,李占淳,梁文妹
ZHANG Pu,LI Rongrong,LI Yixin,LI Zhanchun,LIANG Wenmei

DOI: 10.19367/j.cnki.1000-2707.2014.02.010

参考文献(References)：

• [1]Daneman D.State of the world’s children with diabetes[J].Pediatric Diabetes,2009(2):120-126.
• [2]Rackietan N,Rackietan ML,Nadkarni MR.Studies on diabetogenic action of streptozotocin(NSC-367917)[J].Cancer Chemother Rep,1963(1):91-98.
• [3]Li Z,Karlsson FA,Sandler S.Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice[J].J Endocrinol,2000(1):93-99.
• [4]Müller A,Schott-Ohly P,Dohle C,et al.Differential regulation of Thl-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6J and BALB/c mice by multiple low doses of streptozotocin[J].Immunobiology,2002(1):35-50.
• [5]Yang Z,Chen M,Fialkow LB,et al.The novel anti-inflammatory compound,lisofylline,prevents diabetes in multiple low-dose streptozotocin-treated mice[J].Pancreas,2003(4):99-104.
• [6]Shehata AM1,Quintanilla-Fend L,Bettio S,et al.Prevention of multiple low-dose streptozotocin(MLD-STZ)diabetes in mice by an extract from gum resin of Boswellia serrata(BE)[J].Phytomedicine,2011(12):1037-1044.
• [7]Rees DA,Alcolado JC.Animal models of diabetes mellitus[J].Diabetes Med,2005(4):359-370.
• [8]魏荣锐,苗明三.糖尿病动物模型及特点分析[J].中医研究,2010(2):7-11.
• [9]刘科宇,王春华,杜智敏.链脲佐菌素致大鼠高血糖模型的实验研究[J].哈尔滨医科大学学报,2006(4):272-274.
• [10]宋旸,朴松兰,盛春华,等.STZ诱导C57BL小鼠T1DM模型优化的研究[J].中国实验诊断学,2007(1):36-39.
• [11]Matteucci E,Giampietro O.Proposal open for discussion:defining agreed diagnostic procedures in experimental diabetes research[J].J Ethnopharmacol,2008(2):163-172.
• [12]Purrello F,Rabuazzo AM.Metabolic factors that affect beta-cell function and survival[J].Diabetes Nutr Metab,2000(2):84-91.
• [13]何敏,眭道顺.2型糖尿病患者检测空腹血清胰岛素的临床价值[J].现代医院,2006(7):26-27.
• [14]Sia C.Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus[J].Rev Diabet Stud,2005(4):182-186.
• [15]Ryden A,Stechova K,Durilova M,et al.Switch from a dominant Thl-associated immune profile during the prediabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes[J].Diabetes Metab Res Rev,2009(4):335-343.
• [16]Strandell E,Kaas A,Hartoft-Nielsen ML,et al.Cytokine production in NOD mice on prophylactic insulin therapy[J].APMIS,1999(4):413-419.
• [17]高云,何权瀛,马艳良.胰岛素对体外培养人淋巴细胞生成Thl/Th2因子平衡的调节作用[J].中国糖尿病杂志,2007(2):107-108.
• [18]谢正福,何权瀛,叶阮健,等.大鼠胰岛B细胞功能对Th1/Th2淋巴细胞分化的影响[J].中国实用内科杂志,2004(7):414-416.

文章评论(Comment)：